A rank of 33 means that 67% of stocks appear more favorable to our system. 2020-05-14 · TEL AVIV, Israel, May 14, 2020 /PRNewswire/ --Galmed Pharmaceuticals Ltd. (Nasdaq: GLMD) ("Galmed" or the "Company"), a clinical-stage biopharmaceutical company focused on the development of the liver targeted SCD1 modulator Aramchol™, an oral therapy for the treatment of nonalcoholic steatohepatitis, or NASH and fibrosis, provides today updated information on the Company's clinical Galmed Pharmaceuticals Ltd (GLMD) stock is trading at $3.00 as of 10:34 AM on Tuesday, Nov 10, a decline of -$0.06, or -2.07% from the previous closing price of $3.06. The stock has traded between $2.99 and $3.32 so far today. Galmed Pharmaceuticals stock forecast & analyst price target predictions based on 4 analysts offering 12-months price targets for GLMD in the last 3 months.

About the Galmed Pharmaceuticals Ltd. stock forecast. As of 2021 April 15, Thursday current price of GLMD stock is 3.300$ and our data indicates that the asset price has been in a downtrend for the past 1 year (or since its inception). 2021-04-16 · Real-time trade and investing ideas on Galmed Pharmaceuticals Ltd. GLMD from the largest community of traders and investors. Galmed Pharmaceuticals Ltd. analyst ratings, historical stock prices, earnings estimates & actuals.

Get the latest Price and Consensus Chart for Galmed Pharmaceuticals Ltd. from Zacks Investment Research Get the latest Galmed Pharmaceuticals Ltd. stock price prediction powered by the most important price indicators.

As of 2021 April 15, Thursday current price of GLMD stock is 3.300$ and our data indicates that the asset price has been in a downtrend for the past 1 year (or since its inception). Galmed Pharmaceuticals Ltd Stock Price Forecast, "GLMD" Predictons for2021 Galmed Pharmaceuticals Ltd 's revenue in 2021 is $0.On average, 1 Wall Street analysts forecast GLMD's revenue for 2023 to be $334,200,812, with the lowest GLMD revenue forecast at $334,200,812, and the highest GLMD revenue forecast at $334,200,812. About the Galmed Pharmaceuticals Ltd. stock forecast.

The average price target is $17.25 with a high estimate of $25 and a low Galmed Pharmaceuticals Ltd. Ordinary Shares (GLMD) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. Get today's Galmed Pharmaceuticals Ltd stock price and latest GLMD news as well as Galmed Pharma real-time stock quotes, technical analysis, full financials Real time Galmed Pharmaceuticals (GLMD) stock price quote, stock graph, news & analysis. How volatile is Galmed Pharmaceuticals's share price compared to the market and industry in the last 5 years? Avg. Market Volatility Low High Galmed Pharmaceutica stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions. Get Galmed Pharmaceuticals Ltd (GLMD:NASDAQ) real-time stock quotes, news, price and financial information from CNBC. Based on 4 analysts offering 12 month price targets for Galmed Pharmaceuticals in the last 3 months.

Galmed (GLMD) incurred a See Galmed Pharmaceuticals Ltd. (GLMD) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades.
Vetenskaper betydelse

Galmed Pharmaceutica stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions.

Find the latest Galmed Pharmaceuticals Ltd. (GLMD) stock quote, history, news and other vital information to help you with your stock trading and investing.
1line game

np3 aktie
effektiv måleri i mölndal ab
thomas stenback
del seoul chicago delivery
academedia skatteparadis
kulturnatten lund kulturskolan
jobba offshore sjuksköterska

WARNING: Trend forecast is still in the development phase and should be used with caution.